E
Errol R. Norwitz
Researcher at Tufts University
Publications - 328
Citations - 12185
Errol R. Norwitz is an academic researcher from Tufts University. The author has contributed to research in topics: Pregnancy & Preeclampsia. The author has an hindex of 56, co-authored 324 publications receiving 10598 citations. Previous affiliations of Errol R. Norwitz include Leiden University Medical Center & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Implantation and the survival of early pregnancy.
TL;DR: This review summarizes current information about these steps, including some of the molecular mechanisms that mediate them and how they may go awry, with consequent loss of the pregnancy.
Journal ArticleDOI
The control of labor.
TL;DR: In normal labor, there appears to be a time-dependent relation between the biochemical changes in the connective tissue in the cervix that usually precede uterine contractions and cervical dilatation and the spontaneous rupture of the fetal.
Journal ArticleDOI
Defective implantation and placentation : laying the blueprint for pregnancy complications
TL;DR: An improved understanding of the molecular mechanisms responsible for abnormal implantation and placentation will likely improve clinicians' abilities to treat disorders that occur along this continuum, including infertility, recurrent pregnancy loss, pre-eclampsia, and preterm birth.
Journal Article
Contemporary Diagnosis and Management of Preterm Premature Rupture of Membranes
TL;DR: Management options include admission to hospital, amniocentesis to exclude intra-amniotic infection, and administration of antenatal corticosteroids and broad-spectrum antibiotics, if indicated.
Journal ArticleDOI
Impact of a comprehensive patient safety strategy on obstetric adverse events
Christian M. Pettker,Stephen F. Thung,Errol R. Norwitz,Catalin S. Buhimschi,Cheryl Raab,Joshua A. Copel,Edward Kuczynski,Charles J. Lockwood,Edmund F. Funai +8 more
TL;DR: A systematic strategy to decrease obstetric adverse events can have a significant impact on patient safety, and this initiative significantly reduced the Adverse Outcome Index.